Cargando…
Effect of Crohn’s Disease on Villous Length and CYP3A4 Expression in the Pediatric Small Intestine
Changes in absorptive capacity and first‐pass metabolism in the small intestine affect oral drug bioavailability. Characterization of such changes as a consequence of inflammation is important for developing physiologically‐based pharmacokinetic (PBPK) models for inflammatory bowel disease. We sough...
Autores principales: | Vyhlidal, Carrie A, Chapron, Brian D., Ahmed, Atif, Singh, Vivekanand, Casini, Rebecca, Shakhnovich, Valentina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993283/ https://www.ncbi.nlm.nih.gov/pubmed/33278326 http://dx.doi.org/10.1111/cts.12938 |
Ejemplares similares
-
Impact of Duodenal Pathology on Oral Drug Bioavailability and Disease Outcomes in Pediatric Crohn’s Disease
por: Casini, Rebecca, et al.
Publicado: (2023) -
Characterization of the Mucosally-Adherent Duodenal Microbiome in Children with and without Crohn’s Disease
por: Schmidt, Kenneth, et al.
Publicado: (2022) -
Decreased Pregnane X Receptor Expression in Children with Active Crohn’s Disease
por: Shakhnovich, Valentina, et al.
Publicado: (2016) -
Validation study of villous atrophy and small intestinal inflammation in Swedish biopsy registers
por: Ludvigsson, Jonas F, et al.
Publicado: (2009) -
Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge
por: Martins, Cláudio, et al.
Publicado: (2016)